Coronary Thromboaspiration and Infarct Size

Sponsor
University Hospital, Clermont-Ferrand (Other)
Overall Status
Terminated
CT.gov ID
NCT00456066
Collaborator
(none)
50
1
18
2.8

Study Details

Study Description

Brief Summary

Distal embolization can occur during coronary angioplasty performed in the acute phase of myocardial infarction and is associated with poor long-term outcome. We hypothesize that the use of a system allowing thrombus aspiration before angioplasty and stent implantation will limit infarct size and its severity.

Condition or Disease Intervention/Treatment Phase
  • Device: Export Aspiration System
N/A

Detailed Description

Patients scheduled for emergency angioplasty in the acute phase of a first ST-elevation myocardial infarction will be treated either by thromboaspiration followed by angioplasty or by angioplasty alone. The infarct size and severity will be assessed by ce-MRI and rest Tc99m-mibi gated SPECT performed during initial hospital stay (5th-8th day). A control MRI will be performed at 6-month follow-up to analyse the evolution of left ventricular volumes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Assessment of Efficacity of Coronary Thromboaspiration (Export System) Performed Before Angioplasty on Infarct Size in Patients Treated by Coronary Percutaneous Interventions During Acute Phase.
Study Start Date :
Jun 1, 2006
Actual Primary Completion Date :
Dec 1, 2007
Actual Study Completion Date :
Dec 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Infarct size and severity assessed by ce-MRI and rest Tc99m-mibi gated SPECT [by ce-MRI and rest Tc99m-mibi gated SPECT]

Secondary Outcome Measures

  1. Probability of evolution toward left ventricular remodelling (defined as an increase of end-diastolic volume of>20% between the acute phase and 6-montcontrol) [of end-diastolic volumeof>20% between the acute phase and 6-montcontrol)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • acute phase of myocardial infarction (>48 hours from the onset of chest pain)

  • stable hemodynamic conditions

  • completely occluded infarct related artery

Exclusion Criteria:
  • heart failure signs in the acute phase

  • contra indication for MRI or SPECT IMAGING

Contacts and Locations

Locations

Site City State Country Postal Code
1 Departement of Cardiology and Radiology, University Hospital, and Departement of Nuclear Medicine, Jean Perrin Cancer Centre Clermont-Ferrand Auvergne France 63000

Sponsors and Collaborators

  • University Hospital, Clermont-Ferrand

Investigators

  • Principal Investigator: Janusz Lipiecki, Pr,

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00456066
Other Study ID Numbers:
  • CHU63-0018
First Posted:
Apr 4, 2007
Last Update Posted:
Oct 8, 2008
Last Verified:
Oct 1, 2008

Study Results

No Results Posted as of Oct 8, 2008